Effect of heat-treatment and the role of phospholipases on Fungizone®-induced cytotoxicity within human kidney proximal tubular (HK-2) cells and Aspergillus fumigatus

International Journal of Pharmaceutics

Volumn 298, Issue 1, 2005, Pages 211-218

  Leon, Carlos ^a   Taylor, Ross ^a   Bartlett, Karen H ^a   Wasan, Kishor M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Aspergillus fumigatus; Fungizone ; Heat treated amphotericin B; Human kidney cells; Phospholipases; Renal toxicity

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; PHOSPHOLIPASE; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; SNAKE VENOM;

ARTICLE; ASPERGILLUS FUMIGATUS; CELL GROWTH; CELL LINE; CELL RESPIRATION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; FUNGUS ISOLATION; HEAT TREATMENT; HUMAN; HUMAN CELL; INCUBATION TIME; KIDNEY CELL; KIDNEY PROXIMAL TUBULE; MINIMUM INHIBITORY CONCENTRATION; MITOCHONDRION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; CELL LINE; HEAT; HUMANS; KIDNEY TUBULES, PROXIMAL; MICELLES; PHOSPHOLIPASES;

EID: 20444444217     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.04.018     Document Type: Article

References (38)

1. J. Aufenanger, W. Zimmer, and R. Kattermann Characteristics and clinical application of a radiometric Escherichia coli-based phospholipase A2 assay modified for serum analysis Clin. Chem. 39 1993 605 613
2. B. Baas, K. Kindt, A. Scott, J. Scott, P. Mikulecky, and S.C. Hartsel Activity and kinetics of dissociation and transfer of amphotericin B from a novel delivery form AAPS PharmSci. 1 1999 1 11
3. K. Barrett-Bee, Y. Hayes, R.G. Wilson, and J.F. Ryley A comparison of phospholipase activity, cellular adherence and pathogenicity of yeasts J. Gen. Microbiol. 131 1985 1217 1221
4. K.H. Bartlett, E. Yau, S.C. Hartsel, A. Hamer, G. Tsai, D. Bizzotto, and K.M. Wasan Effect of heat-treated amphotericin B on renal and fungal cytotoxicity Antimicrob. Agents Chemother. 48 2004 333 336
5. M. Birch, G. Robson, D. Law, and D.W. Denning Evidence of multiple extracellular phospholipase activities of Aspergillus fumigatus Infect. Immun. 64 1996 751 755
6. G.P. Bodey Infection in cancer patients: a continuing association Am. J. Med. 81 11 1986 26
7. D.S. Burgess, and R.W. Hastings A comparison of dynamic characteristics of fluconazole, itraconazone, and amphotericin B against Cryptococcus nroformans using time-kill methodology Diagn. Microbiol. Infect. Dis. 38 2000 87 93
8. G.G. Chabot, R. Pazdur, F.A. Valeriote, and L.H.H. Baker Pharmacokinetics and toxicity of continuous infusion of amphotericin B in cancer patients J. Pharm. Sci. 78 1989 307 310
9. P. Chavanet, V. Joly, D. Rigaud, J. Bolard, C. Carbon, and P. Yenni Influence of diet on experimental toxicity of amphotericin B deoxycholate Antimicrob. Agents Chemother. 38 1994 963 968
10. S. Costa, and M. Nucci Can we decrease amphotericin nephrotoxicity? Curr. Opin. Crit. Care 7 2001 379 383
11. E. Dannaoui, J.F.G.M. Meis, J.W. Mouton, and P.E. Verweij In vitro susceptibilities of zygomycota to polyenes J. Antimicrob. Chemother. 49 2002 741 744
12. P.J. Ferguson, C. Currie, and M.D. Vincent Enhancement of platinum-drug cytoxicity in a human head and neck squamous cell carcinoma line and its platinum-resistant variant by liposomal amphotericin B and phospholipase A2-II Drug Metab. Dispos. 27 1999 1399 1405
13. F. Gaboriau, M. Cheron, C. Petit, and J. Bolard Heat-induced superaggregation of amphotericin B reduces its in vitro toxicity: a new way to improve its therapeutic index Antimicrob. Agents Chemother. 41 1997 2345 2351
14. C. Gates, and R.J. Pinney Amphotericin B and its delivery by liposomal and lipid formulations J. Clin. Pharm. Ther. 18 1993 147 153
15. M.A. Ghannoum, A.S. Ibrahim, Y. Fu, M.C. Shafiq, J.E. Edwards Jr., and R.S. Criddle Susceptibility testing of Cryptococcus neoformans: a microdilution technique J. Clin. Microbiol. 30 1992 2881 2886
16. M. Gottfredson, C.J. Jessup, G.M. Cox, J.R. Perfect, and M.A. Ghannoum Fungal phospholipase activity and susceptibility to lipid preparations of amphotericin B Antimicrob. Agents. Chemother. 45 2001 3231 3233
17. S.C. Hartsel, B. Baas, E. Bauer, L.T. Foree, K. Kindt, H. Preis, A. Scott, E.H. Kwong, M. Ramaswamy, and K.M. Wasan Heat-induced superaggregation of amphotericin B modifies its interaction with serum proteins and lipoproteins and stimulation of TNF-a J. Pharm. Sci. 90 2001 124 133
18. E.H. Kwong, M. Ramaswamy, E.A. Bauer, S.C. Hartsel, and K.M. Wasan Heat treatment of amphotericin B modifies its serum pharmacokinetics, tissue distribution, and renal toxicity following administration of a single intravenous dose to rabbits Antimicrob. Agents Chemother. 45 2001 2060 2063
19. M.E. Klesper, E.J. Wolfe, and M.A. Pfaller Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformans J. Antimicrob. Chemother. 41 1998 397 401
20. P.T. Kortesuo, T.J. Nevalainen, M. Buchler, and W. Uhl Characterization of two phospholipases A2 in serum of patients with sepsis and acute pancreatitis Eur. J. Clin. Chem. Clin. Biochem. 30 1992 263 269
21. R.D. Meyer Current role of therapy with amphotericin B Clin. Infect. Dis. 14 1992 S154 S160
22. D.J. Meyers, K.C. Palmer, L.A. Bale, K. Kernacki, M. Preston, T. Brown, and R.S. Berk In vitro and in vivo toxicity of phospholipase C from Pseudomonas aeruginosa Toxicon 30 1992 161 169
23. NCCLS, 2002. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, Approved Standard, second ed. NCCLS document M27-A2 (ISBN 1-56238-469-4) NCCLS, Wayne, PA.
24. M.J. Otero, and L. Carrasco Exogenous phospholipase C permeabilizes mammalian cells to proteins Exp. Cell Res. 177 1988 154 161
25. C. Petit, M. Cheron, V. Joly, J.M. Rodrigues, J. Bolard, and F. Gaboriau In-vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B obtained by mild heating J. Antimicrob. Chemother. 42 1998 779 785
26. C. Petit, V. Yardley, F. Gaboriau, J. Bolard, and S.L. Croft Activity of a heat-induced reformulation of amphotericin B deoxycholate (fungizone) against Leishmania donovani Antimicrob. Agents Chemother. 43 1999 390 392
27. E.P. Reeves, T. Murphy, P. Daly, and K. Kavanagh Amphotericin B enhances the synthesis and release of the immunosuppressive agent gliotoxin from the pulmonary pathogen Aspergillus fumigatus J. Med. Microbiol. 53 2004 719 725
28. P.D. Rogers, K.S. Barker, V. Herring, and M. Jacob Heat-induced superaggregation of amphotericin B attenuates its ability to induce cytokine and chemokine production in human monocytic cell line THP-1 J. Antimicrob. Agents Chemother. 51 2003 405 408
29. D.A. Rothon, R.G. Mathias, and M.T. Schechter Prevalence of HIV infection in provincial prisons in British Columbia Can. J. Med. Assoc. 151 1994 S154 S160
30. M.J. Ryan, G. Johnson, J. Kirk, S.M. Fuerstenberg, R.A. Zager, and B. Torok-Storb HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney Kidney Int. 45 1994 48 57
31. O. Sivak, K. Bartlett, and K.M. Wasan Heat-treated fungizone retains amphotericin B antifungal activity without renal toxicity in rats infected with Aspergillus fumigatus Pharm. Res. 21 2004 1564 1566
32. S. Somji, S.H. Garrett, M.A. Sens, V. Gurel, and D.A. Sens Expression of metallothionein isoform 3 (MT-3) determines the choice between apoptotic or necrotic cell death in Cd+2-exposed human proximal tubule cells Toxicol. Sci. 80 2 2004 358 366
33. C.E. Swenson, W.R. Perkins, P. Roberts, I. Ahmad, R. Stevens, D.A. Stevens, and A.S. Janoff In vitro and in vivo antifungal activity of amphotericin B lipid complex: are phospholipases important? Antimicrob. Agents Chemother. 42 1998 767 771
34. E.W. van Etten, W. van Vianen, P. Roovers, and P. Frederik Mild heating of amphotericin B-desoxycholate: effects on ultrastructure, in vitro activity and toxicity, and therapeutic efficacy in severe candidiasis in leukopenic mice Antimicrob. Agents Chemother. 44 2000 1598 1603
35. K.M. Wasan, M.G. Rosenblum, L. Cheung, and G. Lopez-Berestein Influence of lipoproteins on renal cytotoxicity and antifungal activity of amphotericin B Antimicrob. Agents Chemother. 38 1994 223 227
36. K.M. Wasan, and J.S. Conklin Enhanced Amphotericin B nephrotoxicity in intensive care patients with elevated levels of low-density lipoprotein cholesterol Clin. Infect. Dis. 24 1997 78 80
37. R.A. Zager, K.M. Burkhart, D.S. Conrad, D.J. Gmur, and M. Iwata Phospholipase A2-induced cytoprotection of proximal tubules: potential determinants and specificity for ATP depletion-mediated injury J. Am. Soc. Nephrol. 7 1996 64 72
38. R.A. Zager Polyene antibiotics: relative degrees of in vitro cytotoxicity and potential effects on tubule phospholipid and ceramide content Am. J. Kidney Dis. 36 2000 238 249